What are the Benefits of Exogenous Surfactant Therapy?
The primary benefit of exogenous surfactant therapy is the reduction in mortality and morbidity associated with RDS. Studies have shown that it improves oxygenation, reduces the need for mechanical ventilation, and decreases the incidence of complications such as pneumothorax. It also contributes to shorter hospital stays and better long-term outcomes for premature infants.
